Datum der Indexierung 04.10.2024 23:31:04
erkannte Namen Gene Therapy | Emmanuelle Lecomte | Isabelle Dahinden | Maria Tortoreto | Asia Pacific |
weitere Namen in www.cslbehring.ch 5
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Swissmedic Approval for HEMGENIX®
Kombination Keywords patients rare | hemgenix this | factor from | hemophilia people | with gene | treatment disease | that therapy | behring your | bleeding more | switzerland global |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Factor IX deficiency). HEMGENIX® is a one-time, single-dose treatment option that allows people living with hemophilia B to produce their own factor IX, which can lower the risk of bleeding. The approval is based on results from the ongoing Phase III HOPE-B trial, the largest gene therapy trial in hemophilia B to date. Data from the pivotal trial show that HEMGENIX® reduces the rate of annual bleeding by delivering a functional gene that acts as a blueprint for the production
Text Inhalt Text aus URL
Log Metriken 86111